Can a computer program teach teens to drink less?

NCT ID NCT07713251

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests a computer-based skills training program called Path180 for teenagers aged 13 to 19 with alcohol use disorder. Participants receive either standard treatment or standard treatment plus Path180, a 7-module program that teaches coping skills and motivation to cut back on drinking. The goal is to see if Path180 is feasible, acceptable, and helps reduce heavy drinking days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Path180, a 7-module computer-based skills training program for teenagers to reduce alcohol use
What this could lead to
If effective, Path180 could provide an accessible, scalable tool to help teenagers reduce heavy drinking and improve coping skills, especially for those in underserved communities.
What could go wrong
This is an early feasibility trial with 112 participants, so results may not generalize widely. The computer-based approach may not engage all teens, and benefits over standard treatment alone are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brown University Center for Alcohol and Addiction Studies

    RECRUITING

    Providence, Rhode Island, 02912, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.